- Home
- SCLX vs PEW Comparison
SCLX vs PEW Comparison
Compare SCLX & PEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCLX | PEW |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 143.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SCLX | PEW |
|---|---|---|
| Price | $19.15 | $3.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $6.75 |
| AVG Volume (30 Days) | 122.8K | ★ 589.6K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,360,000.00 | ★ $92,782,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $749.70 | $6.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.60 | $3.26 |
| 52 Week High | $34.27 | $21.40 |
Technical Indicators
Market Signals| Indicator | SCLX | PEW |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 37.01 |
| Support Level | $18.34 | $3.31 |
| Resistance Level | $20.62 | $3.64 |
| Average True Range (ATR) | 2.22 | 0.21 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 32.91 | 33.82 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About PEW GrabAGun Digital Holdings Inc. Common Stock
GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition, and related accessories.